PLAC1 antibody response in NSCLC patients. Graphical representation of the antibody response to PLAC1 in 226 non-small cell lung cancer patients and 78 healthy donors; shown are the reciprocal titers that were calculated for each plasma sample as the maximal dilution still significantly reacting to PLAC1. IRREL refers to the results obtained with the irrelevant protein used as negative control.